Nonalcoholic fatty liver disease, metabolic syndrome, and the fight that will define clinical practice for a generation of hepatologists.
作者信息
Tapper Elliot B, Loomba Rohit
机构信息
Division of Gastroenterology and Hepatology, University of Michigan.
Institute for Healthcare Policy and Innovation, University of Michigan.
出版信息
Hepatology. 2018 May;67(5):1657-1659. doi: 10.1002/hep.29722. Epub 2018 Apr 1.
Abstract
摘要
相似文献
1
Nonalcoholic fatty liver disease, metabolic syndrome, and the fight that will define clinical practice for a generation of hepatologists.非酒精性脂肪性肝病、代谢综合征以及这场斗争将为一代肝病学家界定临床实践。
Hepatology. 2018 May;67(5):1657-1659. doi: 10.1002/hep.29722. Epub 2018 Apr 1.
2
Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists.基层医疗医生和专科医生对非酒精性脂肪性肝炎的认知及相关实践模式
BMC Res Notes. 2016 Mar 11;9:157. doi: 10.1186/s13104-016-1946-1.
3
The Future of Nonalcoholic Fatty Liver Disease Treatment.非酒精性脂肪性肝病治疗的未来。
Med Clin North Am. 2019 Jan;103(1):57-69. doi: 10.1016/j.mcna.2018.08.005. Epub 2018 Nov 1.
4
Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?非酒精性脂肪性肝病与多囊卵巢综合征必然相关而非偶然相关的证据：一种新的肝-卵巢轴？
Endocrine. 2016 Feb;51(2):211-21. doi: 10.1007/s12020-015-0640-8. Epub 2015 May 30.
5
Nonalcoholic fatty liver disease and metabolic syndrome: Shared genetic basis of pathogenesis.非酒精性脂肪性肝病与代谢综合征：发病机制的共同遗传基础
Hepatology. 2016 Nov;64(5):1417-1420. doi: 10.1002/hep.28746. Epub 2016 Aug 24.
6
Nonalcoholic fatty liver disease: are you at risk?
Johns Hopkins Med Lett Health After 50. 2013 Jun;25(4):3.
7
Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?是代谢综合征而非炎症负荷预测炎症性肠病患者的非酒精性脂肪性肝病严重程度吗？
Dig Dis Sci. 2017 Sep;62(9):2604-2606. doi: 10.1007/s10620-017-4665-0. Epub 2017 Jul 4.
8
Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications.儿童非酒精性脂肪性肝病：肝脏及肝外并发症
Pediatr Clin North Am. 2017 Jun;64(3):659-675. doi: 10.1016/j.pcl.2017.01.008.
9
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.非酒精性脂肪性肝病/非酒精性脂肪性肝炎与肝细胞癌。
Clin Liver Dis. 2018 Feb;22(1):201-211. doi: 10.1016/j.cld.2017.08.014.
10
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology.将术语从非酒精性脂肪性肝病改为代谢功能障碍相关脂肪性肝病，这不仅仅是术语的改变。
Clin Mol Hepatol. 2023 Apr;29(2):371-373. doi: 10.3350/cmh.2023.0086. Epub 2023 Mar 14.
引用本文的文献
1
Envisioning how to advance the MASH field.展望如何推动 MASH 领域的发展。
Nat Rev Gastroenterol Hepatol. 2024 Oct;21(10):726-738. doi: 10.1038/s41575-024-00938-9. Epub 2024 Jun 4.
2
Assessing the causal relationships between human blood metabolites and the risk of NAFLD: A comprehensive mendelian randomization study.评估人体血液代谢物与非酒精性脂肪性肝病风险之间的因果关系：一项全面的孟德尔随机化研究。
Front Genet. 2023 Mar 28;14:1108086. doi: 10.3389/fgene.2023.1108086. eCollection 2023.
3
Liver fat content is independently associated with microalbuminuria in a normotensive, euglycaemic Chinese population: a community-based, cross-sectional study.在血压正常、血糖正常的中国人群中，肝脂肪含量与微量白蛋白尿独立相关：一项基于社区的横断面研究。
BMJ Open. 2021 Jun 29;11(6):e044237. doi: 10.1136/bmjopen-2020-044237.
4
Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional study.在初级保健中使用病例识别途径对非酒精性脂肪性肝病患者进行风险分层：一项横断面研究。
CMAJ Open. 2020 May 15;8(2):E370-E376. doi: 10.9778/cmajo.20200009. Print 2020 Apr-Jun.
5
A Novel Automatic Digital Algorithm that Accurately Quantifies Steatosis in NAFLD on Histopathological Whole-Slide Images.一种新颖的自动数字算法，可准确量化非酒精性脂肪性肝病组织病理全切片图像中的脂肪变性。
Cytometry B Clin Cytom. 2019 Nov;96(6):521-528. doi: 10.1002/cyto.b.21790. Epub 2019 Jun 7.
本文引用的文献
1
Projected increase in obesity and non-alcoholic-steatohepatitis-related liver transplantation waitlist additions in the United States.美国肥胖症和非酒精性脂肪性肝炎相关肝移植候补名单人数预计将增加。
Hepatology. 2019 Aug;70(2):487-495. doi: 10.1002/hep.29473. Epub 2018 May 14.
2
Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes After Liver Transplantation: A Systematic Review.肝移植术后不良心血管结局的发生率及风险评估：一项系统评价
Transplantation. 2017 Jul;101(7):1645-1657. doi: 10.1097/TP.0000000000001710.
3
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review.有氧运动与抗阻运动治疗非酒精性脂肪性肝病：系统综述。
J Hepatol. 2017 Jan;66(1):142-152. doi: 10.1016/j.jhep.2016.08.023. Epub 2016 Sep 14.
4
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.非酒精性脂肪性肝病与心血管疾病发病风险：荟萃分析。
J Hepatol. 2016 Sep;65(3):589-600. doi: 10.1016/j.jhep.2016.05.013. Epub 2016 May 17.
5
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
6
We are not in Kansas anymore: The unfamiliar landscape of NASH.我们已不再身处堪萨斯：非酒精性脂肪性肝炎的陌生领域。
Hepatology. 2016 Mar;63(3):682-4. doi: 10.1002/hep.28348. Epub 2016 Jan 5.
7
The global NAFLD epidemic.全球非酒精性脂肪性肝病流行状况。
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):686-90. doi: 10.1038/nrgastro.2013.171. Epub 2013 Sep 17.
Zotero 插件